Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · Astrocytoma Idh-mutant

Astrocytoma Idh-mutant

📧 Sign up to get email alerts when something new happens for Astrocytoma Idh-mutant.

Top drugs studied for this disease

Vorasidenib (2)
Safusidenib (1)
Allogeneic adipose-derived mesenchymal stem cells (1)
Difluoromethylornithine (1)
Telaglenastat (1)
Triapine (1)
Retifanlimab (1)
GI-102 (1)
Temodar (1)
Pembrolizumab (1)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms